Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - ASENSUS SURGICAL, INC. | trxc-ex322_6.htm |
| EX-32.1 - EX-32.1 - ASENSUS SURGICAL, INC. | trxc-ex321_7.htm |
| EX-31.2 - EX-31.2 - ASENSUS SURGICAL, INC. | trxc-ex312_8.htm |
| EX-31.1 - EX-31.1 - ASENSUS SURGICAL, INC. | trxc-ex311_9.htm |
| EX-21.1 - EX-21.1 - ASENSUS SURGICAL, INC. | trxc-ex211_11.htm |
| 10-K - 10-K - ASENSUS SURGICAL, INC. | trxc-10k_20161231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
TransEnterix, Inc.
Morrisville, North Carolina
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-193235, No. 333-199998, No. 333-209485 and No. 333-209486), and on Form S-8 (No. 333-161291, No. 333-190184, No. 333-191011, No. 333-193234, No. 333-197908, No. 333-203950 and No. 333-211972) of TransEnterix, Inc. of our reports dated March 6, 2017, relating to the consolidated financial statements and the effectiveness of TransEnterix, Inc.’s internal control over financial reporting, which appear in this Form 10-K. Our report on the consolidated financial statements contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
/s/BDO USA, LLP
Raleigh, North Carolina
March 6, 2017